title: Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.
authors.forename: J E
authors.initials: JE
authors.lastname: Compston
authors.forename: M
authors.initials: M
authors.lastname: Audran
authors.forename: B
authors.initials: B
authors.lastname: Avouac
authors.forename: G
authors.initials: G
authors.lastname: Bouvenot
authors.forename: J
authors.initials: J
authors.lastname: Devogelaer
authors.forename: R
authors.initials: R
authors.lastname: Eastell
authors.forename: F
authors.initials: F
authors.lastname: Fabris
authors.forename: C
authors.initials: C
authors.lastname: Gennari
authors.forename: E A
authors.initials: EA
authors.lastname: Jones
authors.forename: J M
authors.initials: JM
authors.lastname: Kaufman
authors.forename: E
authors.initials: E
authors.lastname: Lemmel
authors.forename: G
authors.initials: G
authors.lastname: Mazzuoli
authors.forename: D M
authors.initials: DM
authors.lastname: Reid
authors.forename: J D
authors.initials: JD
authors.lastname: Ringe
authors.forename: L
authors.initials: L
authors.lastname: Vanhaelst
authors.forename: R
authors.initials: R
authors.lastname: Ziegler
authors.forename: J Y
authors.initials: JY
authors.lastname: Reginster
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic / Q000592:standards*; D017277:Drug Approval; D004358:Drug Therapy / Q000592:standards*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D005938:Glucocorticoids